BRCA1/2 Mutations – Breast, Ovarian, Pancreatic, Prostate Cancer

Among the most well-known inherited genetic changes connected to a higher risk of various malignancies are mutations in BRCA1 and BRCA2. These genes usually play a vital role in mending damaged DNA and preserving the stability of genetic material. But changes in these genes reduce the body's capacity to properly repair DNA, which increases the risk of several malignancies.
Breast cancer and ovarian cancer, which are linked to BRCA1/2 mutations, typically occur at a younger age than in the general population. People with these mutations also run a higher chance of getting prostate cancer and pancreatic cancer.
Men as well as women can have BRCA1/2 mutations. Men with these mutations run more risks for prostate and pancreatic cancers as well as male breast cancer, even if women are more likely to have breast and ovarian tumours.
For those with a family history of these malignancies or known BRCA mutations, genetic testing is absolutely vital. Early identification by improved screening, lifestyle changes, preventative operations, or focused treatments including PARP inhibitors will greatly improve results and lower cancer risk.
If you have concerns about inherited cancer, please consult a genetic specialist for an accurate assessment and personalised treatment.